Target intelligence / Profile preview

Endo-1,4-beta-xylanase (Xylanase)

Target
Xylanase
Molecular classification
Enzyme, Glycoside hydrolase
01

Overview

Endo-1,4-beta-xylanase is a glycoside hydrolase responsible for the internal cleavage of beta-1,4-xylosidic linkages in xylan, which is the second most abundant polysaccharide in plant cell walls [11, 22]. While humans and other mammals lack the genetic capacity to synthesize this enzyme, it is produced by a wide variety of microorganisms, including bacteria and fungi, to extract energy from plant biomass [3, 8, 17]. Industrially, xylanases are critical processing aids in the baking industry for improving dough stability and volume, and in the paper and pulp industry for the bio-bleaching of pulp [13, 20, 21]. In clinical and pharmacological contexts, xylanase is not typically a target for drug development but is highly relevant as a potent occupational allergen. Exposure to xylanase dust, particularly in bakeries (baker's asthma), can induce IgE-mediated sensitization leading to occupational asthma, allergic rhinitis, and contact dermatitis [1, 5, 23]. Conversely, exogenous xylanases are utilized as active ingredients in oral multi-enzyme digestive supplements designed to improve the digestibility of high-fiber plant foods and reduce symptoms of malabsorption, such as bloating and excessive gas [4, 6, 7]. Recent research also explores its role in modulating the gut microbiome by producing prebiotic xylo-oligosaccharides that support the growth of beneficial bacteria [16, 17].

Other names
1,4-beta-D-xylan xylanohydrolaseEndo-1,4-xylanaseEndoxylanaseBeta-1,4-xylanaseHemicellulase (broadly)
02

Mechanism of action

Endo-1,4-beta-xylanase catalyzes the endohydrolysis of (1->4)-beta-D-xylosidic linkages in xylans, the primary constituent of hemicellulose, converting complex polysaccharides into xylo-oligosaccharides and xylose.

03

Biological functions

Xylan degradationHemicellulose hydrolysisCarbohydrate metabolismPlant cell wall breakdown
04

Disease associations

Occupational asthmaAllergic rhinitisHypersensitivityContact dermatitisIndigestion (therapeutic context)
05

Safety considerations

Occupational sensitizationType I hypersensitivity (Anaphylaxis)Respiratory irritationBronchospasm
06

Biomarkers

Specific IgE antibodies

Beyond the preview

Go deeper on Endo-1,4-beta-xylanase (Xylanase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endo-1,4-beta-xylanase (Xylanase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call